Clinical Trial Update: Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating UCPVax vaccine with or without pembrolizumab added to standard therapy for unmethylated MGMT glioblastoma; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• UCPVax

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Primary Glioblastoma | Phase 2 | Status: NOT_YET_RECRUITING